For the first time, an HIV-positive patient has gone into long-term remission after being treated with a multi-drug cocktail raising hopes of a possible cure on the horizon. The patient, a 34-year-old Brazilian man diagnosed in 2012, was put on a three-drug regimen of antiretroviral therapy (ART) which was intensified with additional antiretrovirals plus a skin cancer preventative called Nicotinamide, a water-soluble version of vitamin B3. Dr. Andrea Savarino, of the Instituto Superiore di Sanitá in Rome, Italy, explained the approach in a presentation to the UK organization AIDSmap prior to the 2020 International AIDS conference in San Francisco. The intensified treatment was stopped after 48 weeks and he returned to his normal three-drug regimen. In March 2019, he began a medically-supervised treatment interruption, stopping his antiretroviral therapy. His last tests (taken on June 22, 2020) show his viral load has remained undetectable, meaning he has maintained viral suppression for more than 65 weeks without antiretroviral medications. The patient’s HIV antibody tests also came back negative. “The virus did not rebound, the viral DNA was maintained negative,” Savarino said. “The antibody response decreased over time, if the antibody decreases, it is possible that the virus has stopped its repetition.” 